| Title | Repetitive response to gemcitabine that led to curative resection in cholangiocarcinoma. | | Author(s) | Kim SH, Kim IH, Kim SW, Lee SO | | Institution | Division of Gastroenterology and Hepatology, Department of Internal Medicine, Chonbuk National University Medical School and Hospital, 634-18, Geum-am dong, Deokjin-gu, Jeonju, Jeonbuk 561-712, South Korea. solee@chonbuk.ac.kr. | | Source | World J Gastroenterol 2009 Sep 28; 15(36):4593-5. | | Abstract | This study reports a case of unresectable intrahepatic mass-forming cholangiocarcinoma which showed a dramatic response to gemcitabine that led to curative resection and a long-term survival of more than five years. Six and five cycles of gemcitabine monotherapy were administered separately over a three-year period and a radical excision was performed at 4.5 years after diagnosis. This case indicates the role of gemcitabine as a neoadjuvant chemotherapeutic agent for cholangiocarcinoma and guarantees a randomized controlled prospective study. | | Language | eng | | Pub Type(s) | Journal Article
| | PubMed ID | 19777621 |
|
